Information to shareholders

Under the Euronext Growth Milan Regulation, anyone holding directly (participation in the share capital with voting rights) or through intermediary persons, trustees or subsidiaries (potential participation) or directly or through interposed persons, trustees or subsidiaries (aggregated participation) at least 5% of a category of financial instruments of Medica SpA is a "Significant Shareholder". Exceeding the 5% threshold and achieving or exceeding (increasing or decreasing) the thresholds of 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6 % and 90% constitute a "Substantial Change" that must be communicated by the Significant Shareholders to Medica SpA. To this end, within 4 trading days, starting from the day on which the transaction involving the Substantial Change was carried out, the Significant Shareholder must notify Medica SpA: the identity of the significant shareholders involved. the date on which Medica SpA was informed. the date on which the Substantial Change occurred in the investments. the price, amount and category of the Medica SpA financial instruments involved. the nature of the operation the nature and extent of the Significant Shareholder's participation in the transaction. The communication can be made using the attached form, sent by e-mail to [email protected] and then sent in original by registered mail to: Medica SpA, Via Degli Artigiani, 7 - 41036 Medolla (MO) – ITALY.

• the identity of the significant shareholders involved.
• the date on which Medica SpA was informed.
• the date on which the Substantial Change occurred in the investments.
• the price, amount and category of the Medica SpA financial instruments involved.
• the nature of the operation
• the nature and extent of the Significant Shareholder's participation in the transaction.

The communication can be made using the attached form, sent by e-mail to [email protected] and then sent in original by registered mail to: Medica SpA, Via Degli Artigiani, 7 - 41036 Medolla (MO) – ITALY.